0001752724-22-062869.txt : 20220316
0001752724-22-062869.hdr.sgml : 20220316
20220316155929
ACCESSION NUMBER: 0001752724-22-062869
CONFORMED SUBMISSION TYPE: N-CEN
PUBLIC DOCUMENT COUNT: 3
CONFORMED PERIOD OF REPORT: 20211231
FILED AS OF DATE: 20220316
DATE AS OF CHANGE: 20220316
EFFECTIVENESS DATE: 20220316
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: HIGHLAND INCOME FUND\MA
CENTRAL INDEX KEY: 0001710680
IRS NUMBER: 456245636
STATE OF INCORPORATION: MA
FISCAL YEAR END: 0630
FILING VALUES:
FORM TYPE: N-CEN
SEC ACT: 1940 Act
SEC FILE NUMBER: 811-23268
FILM NUMBER: 22744803
BUSINESS ADDRESS:
STREET 1: 2515 MCKINNEY AVENUE
STREET 2: SUITE 1100
CITY: DALLAS
STATE: TX
ZIP: 75201
BUSINESS PHONE: 833-697-6246
MAIL ADDRESS:
STREET 1: 2515 MCKINNEY AVENUE
STREET 2: SUITE 1100
CITY: DALLAS
STATE: TX
ZIP: 75201
FORMER COMPANY:
FORMER CONFORMED NAME: HIGHLAND FLOATING RATE OPPORTUNITIES FUND
DATE OF NAME CHANGE: 20170925
FORMER COMPANY:
FORMER CONFORMED NAME: HIGHLAND FLOATING RATE OPPORTUNITIES FUND II
DATE OF NAME CHANGE: 20170628
N-CEN
1
primary_doc.xml
X0404
N-CEN
LIVE
0001710680
XXXXXXXX
811-23268
N-2
HIGHLAND INCOME FUND\MA
811-23268
0001710680
254900CMUE9FRYL2UR80
2515 McKinney Avenue
Suite 1100
DALLAS
75201
US-TX
US
972-934-4700
SEI Investments Global Funds Services
1 Freedom Valley Drive
Oaks
19456
1-610-676-1000
Records as Administrator for Trust
Highland Capital Management Fund Advisors, L.P.
300 Crescent Court
Suite 700
Dallas
75201
1-877-665-1287
Records as Advisor and Administrator for Trust
The Bank of New York Mellon
240 Greenwich Street
New York
10286
1-212-495-1784
Records as Custodian for Trust
NexPoint Securities, Inc.
300 Crescent Court
Suite 700
Dallas
75201
1-972-628-4100
Records as Distributor for Trust
American Stock Transfer & Trust Company, LLC
6201 15th Avenue
Brooklyn
11219
1-800-937-5449
Records As Transfer Agent For Trust
N
N
N-2
Y
Ethan Powell
N/A
N
Pamela Corrie
N/A
N
Bryan A. Ward
N/A
N
John Honis
N/A
Y
Dr. Bob Froehlich
N/A
N
Stephanie Vitiello
N/A
200 Crescent Court, Suite 700
Dallas
75201
XXXXXX
N
N
N
N
NexPoint Securities, Inc.
8-69128
000165013
N/A
Y
N
Cohen & Company, Ltd.
925
N/A
N
N
N
N
N
N
Highland Income Fund
254900CMUE9FRYL2UR80
N
0
0
0
N/A
Y
N
Y
N
N
The Bank of New York Mellon
HPFHU0OQ28E4N0NFVK49
N
N
N/A
909920.40
18213.35
Rule 17a-6 (17 CFR 270.17a-6)
Rule 23c-1 (17 CFR 270.23c-1)
Rule 32a-4 (17 CFR 270.32a-4)
Rule 12d1-1 (17 CFR 270.12d1-1)
Rule 17a-7 (17 CFR 270.17a-7)
N
N
N
N
Highland Capital Management Fund Advisors, L.P.
801-69968
000149653
5493002K2NSYVU046L11
N
American Stock Transfer & Trust Company, LLC
084-00416
254900TS5EWP83BEOU02
N
N
N
Pricing Direct
549300WIC0TOJ7N7GD54
N
IHS Markit
549300HLPTRASHS0E726
GB
N
Intercontinental Exchange, Inc.
5493000F4ZO33MV32P92
N
Thomson Reuters Corporation
549300561UZND4C7B569
CA
N
S&P
549300U4VWNITEKO2881
N
Bloomberg
254900BF4G8VMW8GG471
N
N
The Bank of New York Mellon
HPFHU0OQ28E4N0NFVK49
N
N
Bank - section 17(f)(1) (15 U.S.C. 80a-17(f)(1))
N
American Stock Transfer & Trust Company, LLC
254900TS5EWP83BEOU02
N
N
N
SEI INVESTMENTS GLOBAL FUNDS SERVICES
801-24593
SEC FILE NUMBER
N
N
Highland Capital Management Fund Advisors, L.P.
5493002K2NSYVU046L11
Y
N
N
NexPoint Securities, Inc.
8-69128
000165013
N/A
0.00
JONES TRADING
008-26089
000006888
213800DIYIKDWRCFOC55
3316.84
STIFEL NICOLAUS & CO., INC.
008-01447
000000793
5WUVMA08EYG4KEUPW589
7030.16
RAYMOND JAMES
008-10999
000000705
U4ONQX15J3RO8XCKE979
5272
FRIEDMAN BILLINGS & RAMSEY
008-41426
000025027
549300AEVMODVBY3QS51
62231.96
SOCIETE GENERALE COWEN SECURITIES CORP.
008-40756
000023857
5493008QI0EFC5WBED75
6497.5
JONES & ASSOCIATES
8-26089
000106861
N/A
34384.35
NEWEDGE CANADA
N/A
N/A
N/A
CA
4050
NEW EDGE
008-66125
000128351
549300F35UE0BOM1WJ55
6220
MKM PARTNERS
8-50311
000043552
54930015ODYESNP2QX15
15050.26
NEWEDGE USA, LLC
008-66125
000128351
549300F35UE0BOM1WJ55
9170.9
159474.65
BONY
008-35303
000017481
N/A
78012067.74
GFI SECURITIES LTD LONDON
N/A
N/A
GUNTJCA81C7IHNBGI392
GB
12298220
MIZUHO SECURITIES
008-37710
000019647
7TK5RJIZDFROZCA6XF66
10880000
BROWNSTONE
8-29349
000014055
N/A
40768450.75
BREAN CAPITAL, LLC
8-40742
000023723
254900ZZA1UBVDCNQ378
15853812.50
CANTOR FITZGERALD & CO.
008-00201
000000134
5493004J7H4GCPG6OB62
15229092.64
NOMURA
008-15255
000004297
OXTKY6Q8X53C9ILVV871
16778450
NATIONAL ALLIANCE CAPITAL, LLC
8-48723
000039455
N/A
9445214.53
JPM CHASE
008-35008
000000079
ZBUT11V806EZRVTWT807
8969429.20
BAIRD, ROBERT W., & CO., INCORPORATED
008-00497
000008158
549300772UJAHRD6LO53
21247036.55
523957430.7
N
973618157.17
Other
Common
Common stock
N
N
Common stock
N
N
N
0.74
0.0167
10.99
14.29
true
false
true
false
false
false
LEGAL PROCEEDINGS
2
HFRO_G.1.a.txt
LEGAL PROCEEDINGS
Highland Income Fund
Item G.1.a.i. - Legal Proceedings
Two affiliated funds, including the Highland Income
Fund (f/k/a Highland Floating Rate Opportunities
Fund), are the beneficiaries of an approximately
$122 million judgment against Credit Suisse related
to a syndicated real estate transaction fraudulently
underwritten by the Swiss bank. The judgment was
appealed up to the Dallas Court of Appeals, then the
Texas Supreme Court, remanded to the trial court,
and is back to the Dallas Court of Appeals. The two
funds also are participants in a similar action
against Credit Suisse related to five additional
real estate deals in which the funds allege Credit
Suisse committed fraud in relation to the
underwriting.
INTERNAL CONTROL RPT
3
HFRO_ICL.txt
INTERNAL CONTROL LETTER
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING
FIRM
To the Shareholders and Board of Trustees of
Highland Income Fund
In planning and performing our audit of the
consolidated financial statements of Highland Income
Fund (the Fund) as of and for the year ended
December 31, 2021, in accordance with the standards
of the Public Company Accounting Oversight Board
(United States) (PCAOB), we considered the Funds
internal control over financial reporting, including
controls over safeguarding securities, as a basis
for designing our auditing procedures for the
purpose of expressing our opinion on the
consolidated financial statements and to comply with
the requirements of Form N-CEN, but not for the
purpose of expressing an opinion on the
effectiveness of the Funds internal control over
financial reporting. Accordingly, we express no
such opinion.
The management of the Fund is responsible for
establishing and maintaining effective internal
control over financial reporting. In fulfilling
this responsibility, estimates and judgments by
management are required to assess the expected
benefits and related costs of controls. A funds
internal control over financial reporting is a
process designed to provide reasonable assurance
regarding the reliability of financial reporting and
the preparation of financial statements for external
purposes in accordance with generally accepted
accounting principles (GAAP). A funds internal
control over financial reporting includes those
policies and procedures that (1) pertain to the
maintenance of records that, in reasonable detail,
accurately and fairly reflect the transactions and
dispositions of the assets of the fund; (2) provide
reasonable assurance that transactions are recorded
as necessary to permit preparation of financial
statements in accordance with GAAP, and that
receipts and expenditures of the fund are being made
only in accordance with authorizations of management
and trustees of the fund; and (3) provide reasonable
assurance regarding prevention or timely detection
of unauthorized acquisition, use or disposition of a
funds assets that could have a material effect on
the financial statements.
Because of its inherent limitations, internal
control over financial reporting may not prevent or
detect misstatements. Also, projections of any
evaluation of effectiveness to future periods are
subject to the risk that controls may become
inadequate because of changes in conditions, or that
the degree of compliance with the policies or
procedures may deteriorate.
A deficiency in internal control over financial
reporting exists when the design or operation of a
control does not allow management or employees, in
the normal course of performing their assigned
functions, to prevent or detect misstatements on a
timely basis. A material weakness is a deficiency,
or combination of deficiencies, in internal control
over financial reporting, such that there is a
reasonable possibility that a material misstatement
of the Funds annual or interim financial statements
will not be prevented or detected on a timely basis.
Our consideration of the Funds internal control over
financial reporting was for the limited purpose
described in the first paragraph and would not
necessarily disclose all deficiencies in internal
control that might be material weaknesses under
standards established by the PCAOB. However, we
noted no deficiencies in the Funds internal control
over financial reporting and its operation,
including controls over safeguarding securities,
that we consider to be a material weakness as
defined above as of December 31, 2021.
This report is intended solely for the information
and use of management and the Board of Trustees of
the Fund and the Securities and Exchange Commission
and is not intended to be and should not be used by
anyone other than these specified parties.
COHEN & COMPANY, LTD.
Cleveland, Ohio
March 04, 2022